A
t the centre of NIH’s investment strategy is the goal to raise investment capital, grow through enhancing partnerships, proactively pursue profitable transactions in diversified sectors, restructure the NIH operating model, and generate shareholder value from invested capital.
NIH commits to indentifying attractive business models and value propositions that have shown good financial performance and projections and are in line with our mandate to preserve and grow the capital base of the company and its relationships.